CCR2 silencing in mice with acute myocarditis reduced the migration of granulocyte-macrophage progenitor cells from the bone marrow into the blood, suggesting that this strategy may indicate a pathway for successful treatment of myocarditis. The gene discussed is CCR2; the disease is myocarditis.